Trade Summary

3 days ago, Ostrowski Erik, serving as SVP, CFO, CBO & Treasurer at Akebia Therapeutics, Inc. (AKBA), sold 56,019 shares at $1.11 per share, for a total transaction value of $62,181.09. Following this transaction, Ostrowski Erik now holds 616,616 shares of AKBA.

This sale represents a 8.33% decrease in Ostrowski Erik's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 29, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 1, 2026 at 4:34 PM ET, 2 days after the trade was made.

Akebia Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.